Novartis forges UC Berkeley pact, sees drug hopefuls in three years

Novartis’s NOVN.S research head expects an alliance with a University of California chemistry lab to produce drug candidates within three years as the Swiss company accelerates its hunt for new medicines. Novartis hopes Berkeley scientists including Daniel Nomura, the professor who runs the lab, will speed its search for the Achilles’ heels of hard-to-treat diseases.